Equities

Micro-Tech Nanjing Co Ltd

688029:SHH

Micro-Tech Nanjing Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CNY)64.12
  • Today's Change-0.33 / -0.51%
  • Shares traded1.78m
  • 1 Year change-28.60%
  • Beta0.8043
Data delayed at least 15 minutes, as of Apr 18 2024 08:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Micro-Tech Nanjing Co Ltd is a China-based company principally engaged in the research and development, manufacturing and sales of minimally invasive medical devices. The Company's main products include three series of endoscopic diagnosis and treatment instruments used with endoscopes, microwave ablation equipment and consumables, and disposable endoscopes. Endoscopic diagnosis and treatment equipment mainly includes biopsy, hemostasis and closure, Endoscopic Mucosal Resection (EMR)/Endoscopic Submucosal Dissection (ESD), dilation, and Endoscopic Retrograde Cholangiopancreatography (ERCP), Endoscopic Ultrasonography (EUS) and Endobronchial Ultrasound (EBUS) products. Microwave ablation mainly includes microwave ablation instrument and microwave ablation needle series products. Disposable endoscope mainly includes disposable biliopancreatic imaging system (choledochoscope) and related consumables and other products.

  • Revenue in CNY (TTM)2.48bn
  • Net income in CNY527.90m
  • Incorporated2000
  • Employees2.40k
  • Location
    Micro-Tech Nanjing Co LtdNo. 10, Gaoke 3rd RoadNanjing High-tech Development ZoneNANJING 210032ChinaCHN
  • Phone+86 2 558648819
  • Fax+86 2 558744269
  • Websitehttp://www.micro-tech.com.cn/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Shandong Weigao Orthopaedic Devce Co Ltd1.24bn53.08m10.26bn2.21k192.892.64--8.260.1330.1333.109.730.23690.66543.46561,846.201.0510.971.3413.6960.9077.334.4227.083.37--0.016117.90-30.551.17-79.36-19.11-4.31--
Beijing Wandong Medical Technolgy Co Ltd1.29bn191.36m10.55bn1.06k55.172.22--8.170.27190.27191.836.750.24442.334.281,218,206.003.705.304.126.2140.8145.2115.1416.4610.29--0.014435.8210.305.327.514.22-16.665.39
Shinva Medical Instrument Co Ltd10.10bn668.52m11.12bn8.21k16.571.47--1.101.441.4421.6216.180.67852.225.361,230,542.004.634.639.1810.7626.2224.226.836.120.7893--0.17615.917.87-0.534230.7895.70-5.9061.86
Shanghai Microport EP MedTech Co Ltd366.21m19.18m11.93bn577.00622.037.06--32.590.04080.04080.77823.590.20131.189.01634,687.401.05--1.11--61.35--5.24--12.39--0.014--26.46--85.17------
Micro-Tech Nanjing Co Ltd2.48bn527.90m13.44bn2.40k25.443.60--5.422.812.8113.2319.860.59481.626.911,032,216.0012.9110.7414.9812.8264.8163.0421.7119.375.19--0.0135.4321.7821.2046.9920.3239.33--
Shenzhen YHLO Biotech Co Ltd1.82bn339.81m13.98bn1.76k41.305.32--7.660.59560.59563.214.620.47981.114.911,037,196.007.0316.439.1224.1662.1453.2614.6620.011.50--0.187230.28-48.4223.02-64.9356.3228.88--
Shanghai MicroPort Edvcl MdTch Grp CoLtd1.26bn551.89m15.26bn908.0025.243.78--12.127.317.3116.8048.870.37691.607.961,387,329.0016.3517.6818.1219.4375.6176.6043.3942.259.49--0.00844.4632.4338.7237.9840.2850.18--
Beijing Balance Medical Technolgy Co Ltd382.01m111.83m15.58bn473.00140.5412.90--40.780.81150.81152.778.840.30611.065.72807,636.208.168.068.488.4089.4089.4126.6730.029.77--0.009469.1925.5727.3521.0928.10125.94--
Eyebright Medical Tchnlgy Beijing Co Ltd1.07bn328.48m16.48bn2.07k50.277.44--15.383.123.1210.1621.050.40031.995.19516,774.6011.519.9913.2711.1672.2481.2928.7434.662.48--0.133919.9164.1449.5930.6371.8038.83--
Data as of Apr 18 2024. Currency figures normalised to Micro-Tech Nanjing Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

21.15%Per cent of shares held by top holders
HolderShares% Held
Schroder Investment Management North America, Inc.as of 29 Feb 20247.05m3.83%
Hongde Fund Management Co., Ltd.as of 30 Jun 20236.43m3.49%
ICBC Credit Suisse Asset Management Co., Ltd.as of 08 Feb 20245.28m2.87%
E Fund Management Co., Ltd.as of 08 Feb 20244.82m2.61%
Penghua Fund Management Co., Ltd.as of 30 Jun 20234.59m2.49%
Zhong Ou Asset Management Co., Ltdas of 30 Jun 20233.82m2.07%
Da Cheng Fund Management Co., Ltd.as of 30 Jun 20232.94m1.60%
Hwabao WP Fund Management Co., Ltd.as of 08 Feb 20242.70m1.46%
Harvest Fund Management Co., Ltd.as of 30 Jun 2023689.09k0.37%
China Southern Asset Management Co., Ltd.as of 30 Jun 2023667.37k0.36%
More ▼
Data from 30 Jun 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.